[embedded content]
What You Should Know:
– Google Health and Apollo Radiology International are joining forces to tackle some of the country’s biggest health challenges – tuberculosis (TB), lung cancer, and breast cancer – using AI-powered…
Continue Reading
What You Should Know:
– Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion.
– These strategic deals will bring Lunit’s AI-powered…
Continue Reading
By Shania Kennedy
March 13, 2024 – A research team from Washington University School of Medicine in St. Louis has developed a deep learning (DL)-based approach to help predict which patients with non-small cell lung cancer…
Continue Reading
In 2020, lung cancer, the foremost cause of global cancer-related deaths, took 1.7 million lives, surpassing fatalities from the next three deadliest cancers combined. Early detection significantly improves the five-year survival rate, increasing from…
Continue Reading
What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat…
Continue Reading
Riverrain’s ClearRead CT technology, chosen by the U.S. Department of Veterans Affairs, is transforming lung cancer diagnostics for nearly 8,000 veterans annually. The software’s AI-powered precision measurements promise consistency, alleviating radiology burnout and talent…
Continue Reading
NHS Cheshire and Merseyside’s Radiology Imaging Network (CAMRIN) has secured funding from the NHS Transformation Directorate’s AI Diagnostic Fund to accelerate the deployment of AI to help diagnose lung cancer patients quicker.Up to £1.2…
Continue Reading
What You Should Know:
– Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update,…
Continue Reading
Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer characterized by rapid tumor growth and early metastasis. Accurate prediction of prognosis and therapeutic response is crucial for optimizing treatment strategies…
Continue Reading
The collaborative LungIMPACT study which is gathering real-world evidence of AI-assisted diagnosis of lung cancer, is welcoming East Suffolk and North Essex NHS Foundation Trust.The study brings together UK academia and NHS trusts and…
Continue Reading
